Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Yuanda Pharmaceutical's innovative ophthalmology products ar...

Yuanda Pharmaceutical's innovative ophthalmology products are expected to fill the demand in the hormonal ophthalmic formulation market. No new products have been launched in this market in the past ten years. Clinical trials of GPN00833 have verified its safety and efficacy, so it is expected to meet the demand for safe and potent hormone eye drops. As the ophthalmology market space and surgery volume grow, the market for hormonal ophthalmic preparations will expand.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
See Original
Report
856 Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    3714Followers
    0Following
    8613Visitors
    Follow